In this case, HNSCC cell lines generated from patients with FA (VU-1131 and VU-1365) and also non-FA HNSCCs genetically engineered to inactivate FANCA were used (see materials and methods section; CAL27-C34 and CAL33-C11). This evidence concerns the gene FANCA and head and neck squamous cell carcinoma.